ScreenerHero
CERTCertara, Inc.
NAS · US · Healthcare · Health Information Services · certara.com
8.592USD+2.78%Mkt Cap: 1.28B $P/E: —

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access i…

Industry Peers

Health Information Services
Screen all
VEE
Veeva System Inc. R
$38.07BUSDP/E 44.2
VEEV
Veeva Systems Inc Class A
$40.77BUSDP/E 44.6
BTSG
BrightSpring Health Services Inc. Common Stock
$11.74BUSDP/E 53.0
TEM
Tempus AI Inc. Class A Common Stock
$11.05BUSD
HQY
HealthEquity, Inc.
$8.71BUSDP/E 38.9
TXG
10x Genomics, Inc.
$8.10BUSD
HNGE
Hinge Health Inc. Class A Common Stock
$7.14BUSDP/E 10.8
WAY
Waystar Holding Corp. Common Stock
$4.76BUSDP/E 35.5
DOCS
Doximity, Inc.
$4.62BUSDP/E 30.9
HTFL
Heartflow Inc. Common Stock
$3.96BUSD
PRVA
Privia Health Group, Inc.
$2.75BUSDP/E 97.7
OMCL
Omnicell, Inc.
$1.66BUSDP/E 43.4
OMDA
Omada Health Inc. Common Stock
$1.50BUSDP/E 36.5
SDGR
Schrödinger, Inc.
$1.48BUSD
GDRX
GoodRx Holdings, Inc.
$1.21BUSDP/E 59.0
TDOC
Teladoc Health, Inc.
$1.18BUSD
TALK
Talkspace Inc. Common Stock
$870.57MUSD
HSTM
HealthStream, Inc.
$834.80MUSDP/E 39.7
PHR
Phreesia, Inc.
$738.82MUSDP/E 74.8
CRW
Craneware plc
$564.72MUSDP/E 28.0
HeadlineSourceTime
Older
The Bull Case For Certara (CERT) Could Change Following Wider Q2 Loss And Leadership Shake-Up - Learn Why

In early August 2026, Certara reported second-quarter results showing slightly higher sales of US$93.27 million but a much larger net loss of US$55.27 million, alongside executive reshuffling including the departure of President and Chief Commercial Officer Leif Pedersen and the appointment of Julien Perrier as Chief Commercial Officer and Eric Jahn as Chief Information Officer. At the same time, Certara reaffirmed its 2026 revenue outlook while expanding its share repurchase authorization...

Simply Wall St.
Certara (CERT) Q2 2026 Earnings Call Transcript

Software revenue hit 53% of total as AI-assisted code boosted development 65% year over year.

Motley Fool
Certara, Inc. Q2 2026 Earnings Call Summary

Moby summary of Certara, Inc.'s Q2 2026 earnings call

Moby
Certara Q2 Earnings Call Highlights

Certara (NASDAQ:CERT) reported second-quarter 2026 revenue of $93.3 million, up 1% year over year, as software growth offset a decline in services revenue. Management reaffirmed its full-year revenue outlook while outlining further changes to its commercial organization, cost structure and artificia

MarketBeat
Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates

Certara (CERT) delivered earnings and revenue surprises of -20.00% and -5.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Bank of America Securities Reiterates Buy Rating on Nvidia (NVDA)
IInsider Monkey
NVIDIA (NVDA): The Best NASDAQ 100 Stock to Buy Other Than SpaceX
IInsider Monkey
AI Chips Today - Certara-NVIDIA Partnership Revolutionizes AI in Drug Development
Simply Wall St.
Certara teams up with Nvidia to strengthen AI platform with BioNeMo toolkit (CERT)
InvestorsHub
Is Certara (CERT) Quietly Recasting Its Small-Cap Identity Around Biosimulation Advisory Leadership?
Simply Wall St.
Will CONMED’s New CFO Shift CNMD’s Financial Playbook Or Deepen Its Existing Strategy?
Simply Wall St.
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets
Simply Wall St.
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference
MarketBeat
How Certara (CERT) Investors Can Read The Quiet Shift In The Valuation Story
Simply Wall St.
Is Now An Opportune Moment To Examine Certara, Inc. (NASDAQ:CERT)?
Simply Wall St.